Jasmeer Preet Chhatwal, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alzheimer Disease | 95 | 2023 | 8037 | 4.750 |
Why?
|
| Amyloid beta-Peptides | 62 | 2023 | 3587 | 3.740 |
Why?
|
| tau Proteins | 39 | 2023 | 1868 | 3.170 |
Why?
|
| Positron-Emission Tomography | 54 | 2023 | 6234 | 1.410 |
Why?
|
| Nerve Net | 11 | 2023 | 2174 | 1.350 |
Why?
|
| Brain | 53 | 2023 | 26385 | 1.330 |
Why?
|
| Aniline Compounds | 20 | 2021 | 986 | 1.000 |
Why?
|
| Aging | 16 | 2023 | 8664 | 0.900 |
Why?
|
| Presenilin-1 | 9 | 2023 | 635 | 0.860 |
Why?
|
| Thiazoles | 20 | 2021 | 1483 | 0.840 |
Why?
|
| Carbolines | 5 | 2019 | 265 | 0.830 |
Why?
|
| Presenilin-2 | 6 | 2018 | 106 | 0.790 |
Why?
|
| Extinction, Psychological | 6 | 2008 | 376 | 0.780 |
Why?
|
| Heterozygote | 11 | 2023 | 2804 | 0.760 |
Why?
|
| Amygdala | 6 | 2009 | 1315 | 0.720 |
Why?
|
| Scopolamine | 1 | 2019 | 99 | 0.680 |
Why?
|
| Nerve Degeneration | 2 | 2020 | 748 | 0.670 |
Why?
|
| Cholinergic Antagonists | 1 | 2019 | 165 | 0.640 |
Why?
|
| Amyloidosis | 5 | 2023 | 795 | 0.640 |
Why?
|
| Temporal Lobe | 7 | 2019 | 1670 | 0.630 |
Why?
|
| Memory | 3 | 2019 | 2174 | 0.620 |
Why?
|
| Brain-Derived Neurotrophic Factor | 5 | 2019 | 604 | 0.620 |
Why?
|
| Amyloid beta-Protein Precursor | 8 | 2022 | 1121 | 0.590 |
Why?
|
| Fear | 7 | 2008 | 1440 | 0.530 |
Why?
|
| Magnetic Resonance Imaging | 44 | 2023 | 35421 | 0.520 |
Why?
|
| Atrophy | 11 | 2023 | 1583 | 0.480 |
Why?
|
| Cholecystokinin | 3 | 2009 | 114 | 0.470 |
Why?
|
| Disease Progression | 13 | 2023 | 13284 | 0.470 |
Why?
|
| Longitudinal Studies | 20 | 2023 | 13989 | 0.460 |
Why?
|
| Cerebral Amyloid Angiopathy | 4 | 2023 | 859 | 0.460 |
Why?
|
| Neural Pathways | 3 | 2019 | 2972 | 0.430 |
Why?
|
| Apolipoprotein E4 | 5 | 2019 | 668 | 0.400 |
Why?
|
| Cerebrovascular Disorders | 1 | 2018 | 1504 | 0.390 |
Why?
|
| Hippocampus | 10 | 2021 | 3675 | 0.390 |
Why?
|
| Aged | 56 | 2023 | 163280 | 0.390 |
Why?
|
| Amyloid | 8 | 2023 | 795 | 0.380 |
Why?
|
| Lentivirus | 4 | 2009 | 501 | 0.380 |
Why?
|
| Cerebral Cortex | 7 | 2023 | 5708 | 0.370 |
Why?
|
| Entorhinal Cortex | 4 | 2023 | 272 | 0.360 |
Why?
|
| Down Syndrome | 3 | 2023 | 880 | 0.360 |
Why?
|
| Brain Mapping | 7 | 2021 | 6669 | 0.360 |
Why?
|
| Cerebral Amyloid Angiopathy, Familial | 2 | 2020 | 53 | 0.360 |
Why?
|
| Receptor, Cannabinoid, CB1 | 2 | 2008 | 143 | 0.360 |
Why?
|
| Receptor, Cholecystokinin B | 1 | 2008 | 7 | 0.330 |
Why?
|
| Aged, 80 and over | 32 | 2023 | 57776 | 0.330 |
Why?
|
| Cross-Sectional Studies | 24 | 2023 | 25043 | 0.320 |
Why?
|
| Male | 79 | 2023 | 350118 | 0.320 |
Why?
|
| Humans | 115 | 2023 | 744343 | 0.310 |
Why?
|
| Apolipoproteins E | 7 | 2023 | 1438 | 0.310 |
Why?
|
| Endocannabinoids | 1 | 2008 | 116 | 0.300 |
Why?
|
| Receptors, Cannabinoid | 1 | 2007 | 44 | 0.300 |
Why?
|
| Conditioning, Classical | 2 | 2007 | 366 | 0.290 |
Why?
|
| Peptide Fragments | 8 | 2021 | 5097 | 0.280 |
Why?
|
| Female | 71 | 2023 | 380194 | 0.280 |
Why?
|
| Mutation | 19 | 2023 | 29786 | 0.280 |
Why?
|
| Genes, Dominant | 3 | 2018 | 880 | 0.260 |
Why?
|
| Cognition | 12 | 2023 | 6770 | 0.260 |
Why?
|
| Amyloidogenic Proteins | 5 | 2023 | 152 | 0.260 |
Why?
|
| Cardiovascular Diseases | 2 | 2022 | 15165 | 0.250 |
Why?
|
| Awareness | 2 | 2020 | 640 | 0.240 |
Why?
|
| Fluorodeoxyglucose F18 | 5 | 2021 | 2016 | 0.240 |
Why?
|
| Ethylene Glycols | 3 | 2019 | 156 | 0.230 |
Why?
|
| Cognition Disorders | 1 | 2018 | 4043 | 0.230 |
Why?
|
| Meninges | 2 | 2022 | 190 | 0.220 |
Why?
|
| Proteomics | 4 | 2023 | 3638 | 0.220 |
Why?
|
| Arthrogryposis | 1 | 2023 | 72 | 0.220 |
Why?
|
| Memory Disorders | 3 | 2023 | 1184 | 0.210 |
Why?
|
| Phosphorylation | 7 | 2023 | 8436 | 0.190 |
Why?
|
| Middle Aged | 38 | 2023 | 213383 | 0.190 |
Why?
|
| Cognitive Reserve | 1 | 2021 | 76 | 0.190 |
Why?
|
| Neurofilament Proteins | 2 | 2021 | 318 | 0.190 |
Why?
|
| Receptors, GABA-A | 1 | 2005 | 627 | 0.180 |
Why?
|
| Genetic Vectors | 2 | 2007 | 3420 | 0.180 |
Why?
|
| Plaque, Amyloid | 2 | 2021 | 729 | 0.180 |
Why?
|
| Promoter Regions, Genetic | 3 | 2009 | 5867 | 0.170 |
Why?
|
| Cerebrospinal Fluid | 1 | 2022 | 534 | 0.170 |
Why?
|
| Radiopharmaceuticals | 3 | 2018 | 2645 | 0.170 |
Why?
|
| Adult | 36 | 2023 | 214055 | 0.170 |
Why?
|
| Synaptic Transmission | 1 | 2005 | 1178 | 0.160 |
Why?
|
| TDP-43 Proteinopathies | 1 | 2018 | 38 | 0.160 |
Why?
|
| Atlases as Topic | 1 | 2019 | 236 | 0.160 |
Why?
|
| Apathy | 1 | 2019 | 96 | 0.160 |
Why?
|
| Inheritance Patterns | 1 | 2020 | 340 | 0.150 |
Why?
|
| Corpus Striatum | 2 | 2018 | 1221 | 0.150 |
Why?
|
| Dementia | 2 | 2022 | 2518 | 0.150 |
Why?
|
| Rats, Sprague-Dawley | 6 | 2009 | 8301 | 0.140 |
Why?
|
| Seizures | 2 | 2020 | 2859 | 0.140 |
Why?
|
| Lymphatic Vessels | 1 | 2021 | 353 | 0.140 |
Why?
|
| Family Health | 2 | 2018 | 1282 | 0.140 |
Why?
|
| Mental Status Schedule | 1 | 2016 | 321 | 0.130 |
Why?
|
| Cerebral Hemorrhage | 3 | 2023 | 2647 | 0.130 |
Why?
|
| Avoidance Learning | 2 | 2007 | 233 | 0.130 |
Why?
|
| Central Nervous System | 1 | 2022 | 1357 | 0.130 |
Why?
|
| Diagnostic Self Evaluation | 1 | 2017 | 230 | 0.130 |
Why?
|
| Valine | 1 | 2016 | 413 | 0.120 |
Why?
|
| Risk | 4 | 2020 | 9687 | 0.120 |
Why?
|
| Parietal Lobe | 1 | 2019 | 838 | 0.120 |
Why?
|
| Rats | 7 | 2009 | 24260 | 0.120 |
Why?
|
| Methionine | 1 | 2016 | 590 | 0.120 |
Why?
|
| Activities of Daily Living | 2 | 2023 | 2418 | 0.110 |
Why?
|
| Models, Neurological | 2 | 2020 | 1774 | 0.110 |
Why?
|
| Green Fluorescent Proteins | 3 | 2009 | 2088 | 0.110 |
Why?
|
| Microglia | 1 | 2021 | 1266 | 0.110 |
Why?
|
| Neuropsychological Tests | 4 | 2019 | 6993 | 0.110 |
Why?
|
| Sex Characteristics | 2 | 2023 | 2585 | 0.110 |
Why?
|
| Anxiety | 1 | 2007 | 4297 | 0.110 |
Why?
|
| RNA, Messenger | 6 | 2019 | 13033 | 0.100 |
Why?
|
| Nerve Tissue Proteins | 1 | 2005 | 4462 | 0.100 |
Why?
|
| Frontal Lobe | 1 | 2018 | 1406 | 0.100 |
Why?
|
| Carrier Proteins | 1 | 2005 | 5021 | 0.100 |
Why?
|
| Linear Models | 2 | 2019 | 5952 | 0.100 |
Why?
|
| Neurogranin | 2 | 2022 | 15 | 0.100 |
Why?
|
| Functional Laterality | 1 | 2018 | 2290 | 0.100 |
Why?
|
| Disorders of Excessive Somnolence | 1 | 2013 | 271 | 0.090 |
Why?
|
| Transduction, Genetic | 2 | 2018 | 913 | 0.090 |
Why?
|
| Genetic Association Studies | 1 | 2018 | 2703 | 0.080 |
Why?
|
| Piperidines | 2 | 2008 | 1602 | 0.080 |
Why?
|
| Pentagastrin | 1 | 2008 | 17 | 0.080 |
Why?
|
| Contrast Media | 2 | 2019 | 5300 | 0.080 |
Why?
|
| Geriatric Assessment | 1 | 2016 | 1372 | 0.080 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2021 | 17446 | 0.080 |
Why?
|
| Immunoassay | 2 | 2022 | 752 | 0.080 |
Why?
|
| Macrophages | 1 | 2022 | 5655 | 0.080 |
Why?
|
| Membrane Proteins | 1 | 2005 | 7880 | 0.080 |
Why?
|
| Fibroblasts | 1 | 2018 | 4161 | 0.080 |
Why?
|
| Internationality | 1 | 2013 | 1003 | 0.080 |
Why?
|
| Alleles | 1 | 2019 | 6933 | 0.080 |
Why?
|
| Animals | 14 | 2023 | 168757 | 0.070 |
Why?
|
| Spatial Behavior | 1 | 2007 | 90 | 0.070 |
Why?
|
| Pyrazoles | 2 | 2008 | 1972 | 0.070 |
Why?
|
| Rest | 1 | 2012 | 901 | 0.070 |
Why?
|
| Electrophysiological Phenomena | 1 | 2009 | 315 | 0.070 |
Why?
|
| Diffusion Tensor Imaging | 3 | 2022 | 2305 | 0.070 |
Why?
|
| Receptor, PAR-1 | 1 | 2007 | 113 | 0.070 |
Why?
|
| Models, Theoretical | 1 | 2018 | 3589 | 0.070 |
Why?
|
| Transfection | 2 | 2018 | 5892 | 0.070 |
Why?
|
| Follow-Up Studies | 5 | 2018 | 39050 | 0.070 |
Why?
|
| Association Learning | 1 | 2007 | 224 | 0.070 |
Why?
|
| Receptor, trkB | 1 | 2006 | 125 | 0.070 |
Why?
|
| Flunitrazepam | 1 | 2005 | 20 | 0.070 |
Why?
|
| Immunotherapy | 1 | 2021 | 4445 | 0.070 |
Why?
|
| Stem Cells | 1 | 2018 | 3567 | 0.060 |
Why?
|
| Maze Learning | 1 | 2007 | 478 | 0.060 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2020 | 3923 | 0.060 |
Why?
|
| Asymptomatic Diseases | 2 | 2019 | 551 | 0.060 |
Why?
|
| Epilepsy | 1 | 2020 | 3310 | 0.060 |
Why?
|
| GABA-A Receptor Agonists | 1 | 2005 | 84 | 0.060 |
Why?
|
| Cohort Studies | 7 | 2023 | 40561 | 0.060 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2018 | 8949 | 0.060 |
Why?
|
| Integrases | 1 | 2007 | 533 | 0.060 |
Why?
|
| Mice, Transgenic | 3 | 2022 | 9734 | 0.060 |
Why?
|
| Mice | 8 | 2023 | 81183 | 0.060 |
Why?
|
| Interneurons | 1 | 2009 | 577 | 0.060 |
Why?
|
| Fluorine Radioisotopes | 2 | 2017 | 442 | 0.060 |
Why?
|
| Gene Expression | 2 | 2007 | 7799 | 0.060 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 9438 | 0.060 |
Why?
|
| Phobic Disorders | 1 | 2006 | 439 | 0.060 |
Why?
|
| Transgenes | 1 | 2007 | 1009 | 0.060 |
Why?
|
| Threonine | 1 | 2023 | 279 | 0.060 |
Why?
|
| Signal Transduction | 1 | 2006 | 23403 | 0.060 |
Why?
|
| Intermediate Filaments | 1 | 2023 | 175 | 0.050 |
Why?
|
| Age of Onset | 2 | 2023 | 3271 | 0.050 |
Why?
|
| Genes, Reporter | 1 | 2007 | 1547 | 0.050 |
Why?
|
| Psychiatric Status Rating Scales | 3 | 2017 | 6038 | 0.050 |
Why?
|
| Organ Size | 2 | 2018 | 2252 | 0.050 |
Why?
|
| Prognosis | 3 | 2017 | 29063 | 0.050 |
Why?
|
| Benzodiazepines | 1 | 2008 | 1101 | 0.050 |
Why?
|
| Body Mass Index | 1 | 2020 | 12720 | 0.050 |
Why?
|
| Risk Factors | 5 | 2023 | 72290 | 0.050 |
Why?
|
| Proline | 1 | 2023 | 458 | 0.050 |
Why?
|
| Adolescent | 5 | 2022 | 85781 | 0.050 |
Why?
|
| Rheology | 1 | 2022 | 345 | 0.050 |
Why?
|
| Statistics, Nonparametric | 2 | 2018 | 2886 | 0.050 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2022 | 528 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factor C | 1 | 2021 | 126 | 0.050 |
Why?
|
| Genetic Engineering | 1 | 2007 | 951 | 0.050 |
Why?
|
| In Situ Hybridization | 1 | 2005 | 1950 | 0.050 |
Why?
|
| Gliosis | 1 | 2021 | 245 | 0.050 |
Why?
|
| Biomedical Research | 1 | 2015 | 3309 | 0.040 |
Why?
|
| Neurocalcin | 1 | 2019 | 3 | 0.040 |
Why?
|
| Calibration | 1 | 2022 | 816 | 0.040 |
Why?
|
| Microscopy, Fluorescence | 1 | 2007 | 2699 | 0.040 |
Why?
|
| Synaptosomal-Associated Protein 25 | 1 | 2019 | 52 | 0.040 |
Why?
|
| Chromatography, Liquid | 1 | 2023 | 976 | 0.040 |
Why?
|
| Phencyclidine | 1 | 1998 | 61 | 0.040 |
Why?
|
| Neurologic Examination | 1 | 2022 | 930 | 0.040 |
Why?
|
| Interleukin-12 | 1 | 2021 | 579 | 0.040 |
Why?
|
| Learning | 1 | 2008 | 1713 | 0.040 |
Why?
|
| Hemorrhage | 2 | 2022 | 3461 | 0.040 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2022 | 849 | 0.040 |
Why?
|
| Solubility | 1 | 2020 | 1085 | 0.040 |
Why?
|
| Lewy Bodies | 1 | 2018 | 137 | 0.040 |
Why?
|
| Behavior, Animal | 1 | 2006 | 1881 | 0.040 |
Why?
|
| Endocytosis | 1 | 2022 | 985 | 0.040 |
Why?
|
| Sclerosis | 1 | 2018 | 213 | 0.040 |
Why?
|
| Neurofibrillary Tangles | 1 | 2020 | 439 | 0.040 |
Why?
|
| Encephalitis | 1 | 2021 | 423 | 0.040 |
Why?
|
| Myelin Sheath | 1 | 2021 | 652 | 0.040 |
Why?
|
| Thiones | 1 | 2017 | 46 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2019 | 23338 | 0.040 |
Why?
|
| Blood Pressure | 2 | 2023 | 8554 | 0.040 |
Why?
|
| Depression | 1 | 2017 | 7766 | 0.040 |
Why?
|
| Information Services | 1 | 2018 | 244 | 0.040 |
Why?
|
| Microtubules | 1 | 2023 | 1090 | 0.040 |
Why?
|
| Palmitates | 1 | 2017 | 74 | 0.040 |
Why?
|
| Phagocytosis | 1 | 2022 | 1539 | 0.040 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2023 | 1157 | 0.040 |
Why?
|
| Inflammation | 3 | 2022 | 10638 | 0.040 |
Why?
|
| Acetylcholine | 1 | 1998 | 621 | 0.040 |
Why?
|
| Prevalence | 1 | 2013 | 15226 | 0.030 |
Why?
|
| Benzothiazoles | 1 | 2017 | 248 | 0.030 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 1998 | 449 | 0.030 |
Why?
|
| Karyotyping | 1 | 2018 | 1243 | 0.030 |
Why?
|
| Reproducibility of Results | 3 | 2022 | 19905 | 0.030 |
Why?
|
| Disclosure | 1 | 2022 | 736 | 0.030 |
Why?
|
| Severity of Illness Index | 3 | 2019 | 15540 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2018 | 648 | 0.030 |
Why?
|
| Age Factors | 3 | 2020 | 18370 | 0.030 |
Why?
|
| Sex Factors | 2 | 2019 | 10397 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2022 | 3206 | 0.030 |
Why?
|
| ROC Curve | 1 | 2022 | 3527 | 0.030 |
Why?
|
| Autophagy | 1 | 2021 | 1300 | 0.030 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 1998 | 895 | 0.030 |
Why?
|
| Young Adult | 4 | 2021 | 56430 | 0.030 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2018 | 4042 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2006 | 11366 | 0.030 |
Why?
|
| Haplotypes | 1 | 2018 | 2779 | 0.030 |
Why?
|
| Pedigree | 1 | 2019 | 4644 | 0.030 |
Why?
|
| International Cooperation | 1 | 2018 | 1420 | 0.030 |
Why?
|
| Case-Control Studies | 2 | 2019 | 21746 | 0.020 |
Why?
|
| Dopamine | 1 | 1998 | 1591 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2019 | 2012 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2023 | 2958 | 0.020 |
Why?
|
| Peptides | 1 | 2023 | 4409 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2018 | 2077 | 0.020 |
Why?
|
| Time Factors | 2 | 2017 | 40075 | 0.020 |
Why?
|
| Neuroblastoma | 1 | 2018 | 1226 | 0.020 |
Why?
|
| Psychomotor Performance | 1 | 2018 | 1901 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2018 | 4186 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2019 | 15519 | 0.020 |
Why?
|
| Titrimetry | 1 | 2009 | 36 | 0.020 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2020 | 2737 | 0.020 |
Why?
|
| Residence Characteristics | 1 | 2018 | 2050 | 0.020 |
Why?
|
| Prefrontal Cortex | 1 | 1998 | 2147 | 0.020 |
Why?
|
| Biophysical Phenomena | 1 | 2009 | 327 | 0.020 |
Why?
|
| Biophysics | 1 | 2009 | 383 | 0.020 |
Why?
|
| Cost of Illness | 1 | 2017 | 1859 | 0.020 |
Why?
|
| Brain Concussion | 1 | 2018 | 1320 | 0.020 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2018 | 1736 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2021 | 7722 | 0.020 |
Why?
|
| Genotype | 1 | 2021 | 12951 | 0.020 |
Why?
|
| Prospective Studies | 2 | 2023 | 53288 | 0.020 |
Why?
|
| Patch-Clamp Techniques | 1 | 2009 | 964 | 0.020 |
Why?
|
| Computational Biology | 1 | 2018 | 3521 | 0.020 |
Why?
|
| Phenotype | 1 | 2023 | 16365 | 0.020 |
Why?
|
| Excitatory Amino Acid Agonists | 1 | 2006 | 146 | 0.020 |
Why?
|
| Membrane Potentials | 1 | 2009 | 1137 | 0.020 |
Why?
|
| Electroencephalography | 1 | 2020 | 6150 | 0.020 |
Why?
|
| Receptors, Glutamate | 1 | 2006 | 232 | 0.020 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2018 | 3327 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2014 | 6459 | 0.020 |
Why?
|
| Lysine | 1 | 2009 | 1007 | 0.010 |
Why?
|
| Motor Skills | 1 | 2007 | 522 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2017 | 8324 | 0.010 |
Why?
|
| Plasmids | 1 | 2009 | 2307 | 0.010 |
Why?
|
| MicroRNAs | 1 | 2019 | 3752 | 0.010 |
Why?
|
| Logistic Models | 1 | 2018 | 13408 | 0.010 |
Why?
|
| Gene Targeting | 1 | 2007 | 880 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2018 | 7729 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2018 | 15076 | 0.010 |
Why?
|
| Massachusetts | 1 | 2015 | 8663 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2017 | 12354 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2021 | 18029 | 0.010 |
Why?
|
| Cues | 1 | 2007 | 873 | 0.010 |
Why?
|
| Mice, Knockout | 2 | 2007 | 14557 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2018 | 16689 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 2009 | 2715 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2020 | 77449 | 0.010 |
Why?
|
| Glutamic Acid | 1 | 2006 | 1169 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2015 | 7913 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2007 | 2751 | 0.010 |
Why?
|
| Microdialysis | 1 | 1998 | 158 | 0.010 |
Why?
|
| Algorithms | 1 | 2018 | 13881 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2020 | 20129 | 0.010 |
Why?
|
| Motor Activity | 1 | 2007 | 2714 | 0.010 |
Why?
|
| Psychotherapy | 1 | 2006 | 1643 | 0.010 |
Why?
|
| Cell Line | 1 | 2009 | 15997 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2009 | 19229 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2007 | 21827 | 0.010 |
Why?
|